111 related articles for article (PubMed ID: 24472509)
1. Identification of the interaction region between hemagglutinin components of the botulinum toxin complex.
Suzuki T; Miyashita S; Hayashi S; Miyata K; Inui K; Kondo Y; Miyazaki S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Int J Biol Macromol; 2014 Apr; 65():284-8. PubMed ID: 24472509
[TBL] [Abstract][Full Text] [Related]
2. Reversible Association of the Hemagglutinin Subcomplex, HA-33/HA-17 Trimer, with the Botulinum Toxin Complex.
Sagane Y; Mutoh S; Koizumi R; Suzuki T; Miyashita SI; Miyata K; Ohyama T; Niwa K; Watanabe T
Protein J; 2017 Oct; 36(5):417-424. PubMed ID: 28707196
[TBL] [Abstract][Full Text] [Related]
3. Conformational divergence in the HA-33/HA-17 trimer of serotype C and D botulinum toxin complex.
Sagane Y; Hayashi S; Akiyama T; Matsumoto T; Hasegawa K; Yamano A; Suzuki T; Niwa K; Watanabe T; Yajima S
Biochem Biophys Res Commun; 2016 Aug; 476(4):280-285. PubMed ID: 27237978
[TBL] [Abstract][Full Text] [Related]
4. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.
Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492
[TBL] [Abstract][Full Text] [Related]
5. Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.
Yoneyama T; Miyata K; Chikai T; Mikami A; Suzuki T; Hasegawa K; Ikeda T; Watanabe T; Ohyama T; Niwa K
FEMS Immunol Med Microbiol; 2008 Dec; 54(3):290-8. PubMed ID: 18801042
[TBL] [Abstract][Full Text] [Related]
6. Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components.
Mutoh S; Kouguchi H; Sagane Y; Suzuki T; Hasegawa K; Watanabe T; Ohyama T
Biochemistry; 2003 Sep; 42(37):10991-7. PubMed ID: 12974634
[TBL] [Abstract][Full Text] [Related]
7. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
Kouguchi H; Watanabe T; Sagane Y; Ohyama T
Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
[TBL] [Abstract][Full Text] [Related]
8. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
[TBL] [Abstract][Full Text] [Related]
9. Sugar-induced conformational change found in the HA-33/HA-17 trimer of the botulinum toxin complex.
Sagane Y; Hayashi S; Matsumoto T; Miyashita S; Inui K; Miyata K; Yajima S; Suzuki T; Hasegawa K; Yamano A; Nishikawa A; Ohyama T; Watanabe T; Niwa K
Biochem Biophys Res Commun; 2013 Aug; 438(3):483-7. PubMed ID: 23916708
[TBL] [Abstract][Full Text] [Related]
10. A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.
Hasegawa K; Watanabe T; Suzuki T; Yamano A; Oikawa T; Sato Y; Kouguchi H; Yoneyama T; Niwa K; Ikeda T; Ohyama T
J Biol Chem; 2007 Aug; 282(34):24777-83. PubMed ID: 17581814
[TBL] [Abstract][Full Text] [Related]
11. Four molecules of the 33 kDa haemagglutinin component of the Clostridium botulinum serotype C and D toxin complexes are required to aggregate erythrocytes.
Mutoh S; Suzuki T; Hasegawa K; Nakazawa Y; Kouguchi H; Sagane Y; Niwa K; Watanabe T; Ohyama T
Microbiology (Reading); 2005 Dec; 151(Pt 12):3847-3858. PubMed ID: 16339931
[TBL] [Abstract][Full Text] [Related]
12. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.
Kouguchi H; Suzuki T; Hasegawa K; Mutoh S; Watanabe T; Niwa K; Yoneyama T; Katoh Y; Ohyama T
J Microbiol Methods; 2006 Dec; 67(3):416-23. PubMed ID: 16725219
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi.
Matsuo T; Miyata K; Inui K; Ito H; Horiuchi R; Suzuki T; Yoneyama T; Oguma K; Niwa K; Watanabe T; Ohyama T
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):35-43. PubMed ID: 21635567
[TBL] [Abstract][Full Text] [Related]
14. Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium.
Niwa K; Koyama K; Inoue S; Suzuki T; Hasegawa K; Watanabe T; Ikeda T; Ohyama T
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):346-52. PubMed ID: 17378898
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.
Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Obata S; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2002 Mar; 292(2):434-40. PubMed ID: 11906181
[TBL] [Abstract][Full Text] [Related]
16. Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.
Hasegawa K; Watanabe T; Sato H; Sagane Y; Mutoh S; Suzuki T; Yamano A; Kouguchi H; Takeshi K; Kamaguchi A; Fujinaga Y; Oguma K; Ohyama T
Protein J; 2004 Aug; 23(6):371-8. PubMed ID: 15517984
[TBL] [Abstract][Full Text] [Related]
17. Small-angle X-ray scattering reveals structural dynamics of the botulinum neurotoxin associating protein, nontoxic nonhemagglutinin.
Sagane Y; Miyashita S; Miyata K; Matsumoto T; Inui K; Hayashi S; Suzuki T; Hasegawa K; Yajima S; Yamano A; Niwa K; Watanabe T
Biochem Biophys Res Commun; 2012 Aug; 425(2):256-60. PubMed ID: 22828508
[TBL] [Abstract][Full Text] [Related]
18. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.
Fujinaga Y; Inoue K; Shimazaki S; Tomochika K; Tsuzuki K; Fujii N; Watanabe T; Ohyama T; Takeshi K; Inoue K
Biochem Biophys Res Commun; 1994 Dec; 205(2):1291-8. PubMed ID: 7802661
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Hemagglutinin: Critical Protein for Adhesion and Absorption of Neurotoxin Complex in Host Intestine.
Amatsu S; Fujinaga Y
Methods Mol Biol; 2020; 2132():183-190. PubMed ID: 32306327
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction between subunits of the botulinum toxin complex produced by serotype D through tryptic susceptibility of the isolated components and complex forms.
Suzuki T; Watanabe T; Mutoh S; Hasegawa K; Kouguchi H; Sagane Y; Fujinaga Y; Oguma K; Ohyama T
Microbiology (Reading); 2005 May; 151(Pt 5):1475-1483. PubMed ID: 15870457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
